<DOC>
	<DOC>NCT01102387</DOC>
	<brief_summary>The aim of this study is to determine the efficacy and safety of once daily topical application of the combinational cream LAS41003 compared to the corresponding mono-substances in the treatment of candida infections in intertriginous areas at the trunk.</brief_summary>
	<brief_title>Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<criteria>presence of candida infections in one or more intertriginous areas (trunk), confirmed by positive mycological sample at baseline; female volunteers of childbearing potential must either be surgically sterile (hysterectomy or tubal ligation) or agree to use a reliable method of contraception with a failure rate of less than 1 % per year when used consistently and correctly such as implants, injectables, combined oral contraceptives, some intra uterine devices [IUDs], sexual abstinence or vasectomized partner; written informed consent receiving systemic therapy with cytotoxic or immunosuppressive drugs either concurrently or within 12 weeks before the baseline visit; patients who have been treated with oral antifungal agents within the 12 weeks prior to study entry or treated with topical antifungal agents on the intertrigines within the previous 2 weeks; evidence of drug or alcohol abuse; pregnancy or nursing; symptoms of a clinically significant illness that may influence the outcome of the study in the four weeks before and during the study; treatment with any other investigational drug in the four weeks preceding the study; known allergic reactions to components of the study preparations, hypersensitivity against cetylstearyl alcohol; treatment with systemic or locally acting medications which might counter or influence the study aim within two weeks before the beginning of the study (e.g. glucocorticosteroids); in the opinion of the investigator or physician performing the initial examination the subject should not participate in the study, e.g. due to probable noncompliance or inability to</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Candida infections in intertriginous areas</keyword>
</DOC>